AGP Executive Report
Last update: an hour agoAI & Youth Mental Health: A large JAMA Pediatrics study links affective generative AI use with emotional and mental health problems in children and teens, warning that “AI as emotional refuge” may signal distress. Cancer Care Update: Daiichi Sankyo and Merck voluntarily withdrew a U.S. accelerated approval Biologics License Application for ifinatamab deruxtecan in extensive-stage small cell lung cancer, while continuing Phase 3 enrollment. Primary Care Capacity in B.C.: A new UBC clinic will deliver team-based care for up to 4,450 B.C. patients, aiming to strengthen access. Flu/COVID Access in Ontario: Free flu and COVID-19 shots open to the general public Oct. 26, after priority groups begin receiving doses starting Sept. 28. Health Tech & Research: U of T researchers report engineered tRNA can help cells bypass premature stop mutations, restoring full-length protein production in lab and preclinical models. Public Safety Recall: Health Canada recalls specific Galanz retro fridges due to fire and burn hazards. Policy & Ethics: Canada’s literary prizes say they rely on publishers to screen out AI-written books, while Health Canada and others continue tightening guidance around AI use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.